- Home
- IART
as 07-11-2025 4:00pm EST
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
| Founded: | 1989 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 922.4M | IPO Year: | 1995 |
| Target Price: | $19.43 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.06 - $32.66 | Next Earning Date: | 07-28-2025 |
| Revenue: | $1,624,308,000 | Revenue Growth: | 6.19% |
| Revenue Growth (this year): | 5.56% | Revenue Growth (next year): | 4.41% |
Latest Integra LifeSciences Holdings Corporation News
IART Breaking Stock News: Dive into IART Ticker-Specific Updates for Smart Investing
StockStory
22 days ago
3 Value Stocks Skating on Thin Ice
StockStory
a month ago
3 Volatile Stocks with Bad Fundamentals
Zacks
a month ago
Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?
Argus Research
a month ago
Analyst Report: Integra Lifesciences Hldgs Cor
Argus Research
a month ago
Market Digest: ANF, CIEN, CMS, IART, KVUE
Zacks
a month ago
Integra (IART) Up 2.3% Since Last Earnings Report: Can It Continue?
StockStory
a month ago
Surgical Equipment & Consumables - Specialty Stocks Q1 In Review: Integra LifeSciences (NASDAQ:IART) Vs Peers
StockStory
a month ago
1 of Wall Street’s Favorite Stock Worth Investigating and 2 to Be Wary Of
Compare IART vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IART Integra LifeSciences Holdings Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.